PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 95 filers reported holding PHATHOM PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $94,011,000 | +17.6% | 11,141 | +89.7% | 0.05% | +134.8% |
| Q1 2022 | $79,940,000 | -19.6% | 5,874 | +16.1% | 0.02% | -4.2% |
| Q4 2021 | $99,487,000 | -38.7% | 5,058 | 0.0% | 0.02% | -38.5% |
| Q3 2021 | $162,356,000 | +68.1% | 5,058 | +78.3% | 0.04% | +77.3% |
| Q2 2021 | $96,598,000 | +30.8% | 2,837 | +44.3% | 0.02% | +4.8% |
| Q1 2021 | $73,840,000 | -15.4% | 1,966 | -25.2% | 0.02% | -19.2% |
| Q4 2020 | $87,265,000 | -9.4% | 2,627 | 0.0% | 0.03% | -7.1% |
| Q3 2020 | $96,327,000 | +5.4% | 2,627 | -5.4% | 0.03% | +16.7% |
| Q2 2020 | $91,385,000 | +14.1% | 2,777 | -10.5% | 0.02% | +9.1% |
| Q1 2020 | $80,090,000 | – | 3,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |